GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 802 filers reported holding GLAXOSMITHKLINE PLC in Q2 2019. The put-call ratio across all filers is 0.84 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $11,452,000 | +84.3% | 1,980 | +80.0% | 0.36% | +104.6% |
| Q1 2022 | $6,215,000 | +207066.7% | 1,100 | +316.7% | 0.17% | – |
| Q4 2021 | $3,000 | -92.1% | 264 | – | 0.00% | -100.0% |
| Q3 2021 | $38,000 | -5.0% | 0 | – | 0.02% | +28.6% |
| Q2 2021 | $40,000 | +207.7% | 0 | – | 0.01% | – |
| Q1 2021 | $13,000 | +550.0% | 0 | -100.0% | 0.00% | -100.0% |
| Q4 2020 | $2,000 | -100.0% | 56 | -64.3% | 0.00% | -88.9% |
| Q1 2020 | $5,948,000 | +8161.1% | 157 | -80.7% | 0.02% | -64.0% |
| Q4 2019 | $72,000 | +105.7% | 812 | -1.3% | 0.05% | +66.7% |
| Q3 2019 | $35,000 | +9.4% | 823 | +3.0% | 0.03% | +15.4% |
| Q2 2019 | $32,000 | +52.4% | 799 | +62.7% | 0.03% | +52.9% |
| Q1 2019 | $21,000 | -8.7% | 491 | -17.5% | 0.02% | -29.2% |
| Q3 2018 | $23,000 | +64.3% | 595 | +76.6% | 0.02% | +84.6% |
| Q2 2018 | $14,000 | +7.7% | 337 | +2.4% | 0.01% | 0.0% |
| Q1 2018 | $13,000 | – | 329 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sio Capital Management, LLC | 325,823 | $11,557,000 | 6.52% |
| KAHN BROTHERS GROUP INC | 1,139,163 | $40,406,111,000 | 6.35% |
| Chubb Ltd | 400,000 | $14,188,000 | 6.18% |
| Healthcare Value Capital, LLC | 50,000 | $1,774,000 | 5.40% |
| CLARK ESTATES INC/NY | 650,000 | $23,056,000 | 3.81% |
| PVG ASSET MANAGEMENT CORP | 220,450 | $7,819,361,000 | 3.57% |
| Martin Capital Partners, LLC | 88,195 | $3,128,000 | 3.25% |
| Camber Capital Management LP | 1,500,000 | $53,205,000 | 2.60% |
| EQUITY INVESTMENT CORP | 2,090,120 | $74,137,000 | 2.47% |
| Keystone Financial Planning, Inc. | 129,102 | $4,579,000 | 2.44% |